MEDICAL MARIJUANA INC.

Company Snapshot

Founded: 2005
Entity Type: Public
Region: U.S.
Headquarter: California, U.S.
Key Geographics: U.S.
Corporate Address: 3974 Sorrento Valley Blvd, San Diego, California 92191 U.S. Tel. +1-866-273-8502 www.medicalmarijuanainc.com

Company Overview

Medical Marijuana Inc. incorporated on May 23, 2005 in Poway, Calif., is a development-stage company, that operates in the cannabis and industrial hemp markets in America. Through its subsidiaries and investment holdings, the company focuses on the development, sale and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil. Medical Marijuana Inc. became the first publicly traded marijuana stock in the U.S. in 2009. 

Medical Marijuana Inc.’s products are formulated for the pharmaceutical, nutraceutical and cosmeceutical industries, including dietary supplements and prescription-based hemp oil for sale in countries that have legalized its hemp oil for the treatment of various illnesses and conditions, such as Brazil and Mexico, and skin care products. The company’s services include the development of cannabinoid-based health and wellness products, and the development of medical grade compounds. The company operates through its subsidiaries, including HempMeds, CanChew Biotechnologies LLC, and Kannaway LLC. 

Medical Marijuana Inc. also owns a sizable stake in Axim Biotechnologies.

MEDICAL MARIJUANA INC. In Reports

Conventional and Alternative Pain Treatment Markets

Conventional and Alternative Pain Treatment Markets Report. Get insight on market size and trends and growth forecast.

Cannabidiol (CBD) Oil: Global Markets

The global market for cannabidiol (CBD) oil should grow from $967.2 million in 2020 to $5.3 billion by 2025, at CAGR of 40.4% for the period of 2020-2025.

Non-opioid Pain Treatment: Global Markets to 2024

The global market for non-opioid pain treatments should grow from $13.8 billion in 2019 to $31.8 billion by 2024 at a compound annual growth rate (CAGR) of 18.3% for the period of 2019-2024.

Company's Business Segments

  • Products : CBD products, Weight loss capsules, Nutrition, Vapes, Beauty products, Others
  • Services : Product Distribution, Direct Sales, Research and Development, Others

Applications/End User Industries

  • Healthcare
  • Pharmaceuticals
  • Biotechnology
  • Retail
AI Sentiment